Multiple Sclerosis Current Events

Multiple Sclerosis Current Events, Multiple Sclerosis News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Children with and without multiple sclerosis have differences in gut bacteria
In a recent study, children with multiple sclerosis had differences in the abundance of specific gut bacteria than children without the disease. Certain types of bacteria were either more or less abundant in children with multiple sclerosis. In particular, there was an association between multiple sclerosis and an increase in gut bacteria that have been linked to inflammation and a decrease in gut bacteria that are considered anti-inflammatory. (2016-05-16)

Sun exposure seems to reduce risk of multiple sclerosis
Higher sun exposure during childhood and early adolescence is associated with a reduced risk of multiple sclerosis, finds a study in this week's BMJ. (2003-08-07)

More evidence that stress makes MS symptoms worse
Most patients with multiple sclerosis believe that stressful life events make their symptoms worse, but this theory remains controversial among care providers and academics. (2004-03-18)

Ultra-high-field MRI allows for earlier diagnosis of multiple sclerosis
Ultra-high-field MRI can detect multiple sclerosis lesions better than MRI which can lead to possible earlier diagnosis and treatment, according to a new study by researchers from Ohio State University in Columbus, and Columbia University in New York. (2007-05-04)

Stress makes MS symptoms worse
For patients with multiple sclerosis, stressful life events seem to make their symptoms worse, finds a study in this week's BMJ. (2003-09-18)

Patients with multiple sclerosis in Taiwan may be at increased risk of developing cancer
Individuals with multiple sclerosis may have an increased risk of developing any type of cancer, with an especially high risk of developing breast cancer. That is the conclusion of a recent study published in European Journal of Neurology. Because the findings contradict earlier studies, additional research is needed to determine whether a true link exists between multiple sclerosis and cancer. (2014-01-14)

Government money for multiple sclerosis patients could be better spent
The National Institute for Clinical Excellence (NICE) has announced that neither interferon beta nor glatiramer can be recommended for multiple sclerosis in the NHS. However, the UK government plans to make these drugs available through a risk sharing scheme, despite limited evidence of clinical and cost effectiveness. (2003-02-13)

Questions over accuracy of MRI in diagnosing multiple sclerosis
The accuracy of magnetic resonance imaging (MRI) is not sufficient to rule in or rule out a diagnosis of MS with a high degree of certainty, finds a study published online by the BMJ today. (2006-03-23)

Cannabis extract reduces pain in multiple sclerosis patients
The cannabis extract, dronabinol, reduces pain in patients with multiple sclerosis, finds new research published on (2004-07-15)

Vanderbilt researchers, international team, uncover genes linked to multiple sclerosis
An international team of scientists, including investigators from Vanderbilt University Medical Center's Center for Human Genetics Research, has identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of an important and very debilitating neurological disease. (2011-08-10)

MS research could help repair damage affecting nerves
Multiple sclerosis treatments that repair damage to the brain could be developed thanks to new research. A study has shed light on how cells are able to regenerate protective sheaths around nerve fibers in the brain. (2013-07-21)

Some link between CCSVI and MS but quality of evidence prevents definitive conclusion
Chronic cerebrospinal venous insufficiency (CCSVI) appears to be more common in people with multiple sclerosis than in people without the condition, states a review of published studies in CMAJ (Canadian Medical Association Journal). However, there are not enough high-quality studies to allow definitive conclusions. (2011-10-03)

Medical history reveals multiple sclerosis begins to impact patients sooner
People with multiple sclerosis can show signs of something wrong five years before the onset of disease, much earlier than previously thought, according to a new analysis of health records from people with the condition. (2017-04-20)

New blood cells fight brain inflammation
Hyperactivity of our immune system can cause a state of chronic inflammation. If chronic, the inflammation will affect our body and result in disease. In the devastating disease multiple sclerosis, hyperactivity of immune cells called T-cells induce chronic inflammation and degeneration of the brain. Researchers at BRIC, the University of Copenhagen, have identified a new type of regulatory blood cells that can combat such hyperactive T-cells in blood from patients with multiple sclerosis. (2014-02-16)

University of Akron professor receives grant to help find cure for multiple sclerosis
Leah Shriver Ph.D., an assistant professor in chemistry and biology at The University of Akron, has been awarded a three year $469,000 grant from the National Institute of Health for her research with cell regeneration, the key to curing many brain diseases such as multiple sclerosis (MS). (2016-12-20)

Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
Immune cells called dendritic cells, which were previously thought to contribute to the onset and development of multiple sclerosis, actually protect against the disease in a mouse model, according to a study published by Cell Press in the August issue of the journal Immunity. These new insights change our fundamental understanding of the origins of multiple sclerosis and could lead to the development of more effective treatments for the disease. (2012-08-16)

Long-term effect of interferons for multiple sclerosis still in doubt
Authors of a systematic review in this week's issue of The Lancet highlight how interferons--widely used to treat multiple sclerosis--have no proven effect beyond one year of treatment. (2003-02-13)

Leading experts to discuss latest advances in Parkinson's disease and multiple sclerosis
Some of the country's leading experts in the fields of Parkinson's disease and multiple sclerosis will gather Feb. 19-20, 2011, in Lake Buena Vista, Fla., to discuss the latest advances in the diagnosis and treatment of these neurological disorders. (2011-02-02)

Concern over fast tracking of new drugs
Concerns over the fast tracking of new drugs for commercial licensing are raised by a senior doctor in this week's BMJ. (2006-02-16)

Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting
An educational lunch workshop, (2004-02-06)

Resistance training may slow down the progression of multiple sclerosis
In the past, multiple sclerosis patients were advised not to exercise for fear of exacerbating the illness. However, it is now known that physical training can relieve many of the symptoms, including the excessive fatigue and mobility impairments that are often seen. New research now shows that resistance training may protect the nervous system and thus slow the progression of the disease. (2017-08-01)

Therapy found to relieve fatigue of multiple sclerosis patients
For the first time, researchers here have found an effective therapy that can alleviate the fatigue often accompanying multiple sclerosis. Many therapies have been developed to treat symptoms of multiple sclerosis, but few have helped, to any degree, the excessive, debilitating fatigue that accompanies other disease symptoms in some patients. (2002-01-18)

Consortium of Multiple Sclerosis Centers hosts webcast
A one-hour webcast and teleconference with an interactive Q&A session, hosted by Consortium of Multiple Sclerosis Centers will describe the contemporary vision of multiple sclerosis (MS): the advantages of a comprehensive approach to management; innovative long-term disease management strategies; and an overview of the science of MS and the role of therapy. (2006-02-09)

Cellular self-digestion process triggers autoimmune disease
Autophagy allows cells to degrade and recycle their cellular components. Researchers at UZH have now demonstrated that the autophagy machinery in certain immune cells leads to the immune system attacking the central nervous system. The researchers are using these findings as a basis to look into new approaches to treating autoimmune diseases such as multiple sclerosis. (2017-12-13)

A molecular key for delaying the progression of Multiple Sclerosis is found
In the lab it was possible to improve the symptoms in the chronic phase of the disease while encouraging the repair of the nervous tissue, and the challenge now is to move the research forward in humans. This discovery is the outcome of the work by an international consortium led in the Basque Autonomous Community by the UPV/EHU and the Achucarro centre together with personnel from ciberNed and CICbiomaGUNE. (2018-07-20)

Concussions in adolescence linked with an increased risk of multiple sclerosis
A new study published in the Annals of Neurology found a link between head trauma in adolescence, particularly if repeated, with a raised risk of later developing multiple sclerosis. (2017-09-20)

Second patient with multiple sclerosis undergoes groundbreaking surgery at Yale
A 29-year-old man with multiple sclerosis is the second patient to undergo transplantation surgery at Yale in an effort to repair myelin, the protective brain and spinal cord sheath that is destroyed by the disease, Yale researchers have reported. (2002-03-14)

Study reveals new possibility of reversing damage caused by MS
Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system, a study has shown. (2010-12-05)

Obesity worsens disability in multiple sclerosis
Obesity is an aggravating factor in relapsing-remitting multiple sclerosis, the most common form of the disease. A recent study by the Unit of Neurology and Neurorehabilitation of the I.R.C.C.S. Neuromed in Pozzilli (Italy) confirms that lipid metabolism can have a role in determining the severity of multiple sclerosis. (2019-06-05)

Researchers uncover critical metabolic switch for inflammatory diseases
A research team in Trinity College Dublin has uncovered a critical role for a protein called 'PKM2' in the regulation of immune cell types at the heart of multiple inflammatory diseases. (2019-11-21)

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity. (2020-05-18)

Common cholesterol drug prevents, reverses MS symptoms in mice
Lipitor ™, the most frequently used cholesterol lowering agent in the world, proved effective in reversing paralysis in a mouse model of multiple sclerosis. (2002-04-20)

Majority of children vaccinated against hepatitis B not at increased risk of MS
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a study to be published in the Oct. 8, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology. (2008-09-25)

Past pregnancies linked to reduced MS risk in women
Women who have multiple pregnancies may have a lower risk of developing multiple sclerosis, according to research published in the March 7, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology. (2012-03-07)

UTHealth researchers link multiple sclerosis to different area of brain
Radiology researchers at the University of Texas Health Science Center at Houston (UTHealth) have found evidence that multiple sclerosis affects an area of the brain that controls cognitive, sensory and motor functioning apart from the disabling damage caused by the disease's visible lesions. (2011-12-22)

UCLA study identifies 'designer estrogen' as potential MS drug
While people with multiple sclerosis have many choices for anti-inflammatory drugs to help prevent flare-ups of their physical symptoms, no medication exists to stop MS from causing degeneration of the brain and spinal cord. Now a UCLA study finds that a new form of estrogen protects the brain without increasing the risk of hormone-induced cancers of the breast and uterus. (2007-08-27)

£1.1 million study to reduce cognitive problems in people with MS
Experts in Nottingham are leading a major new study into how people with multiple sclerosis could overcome problems with attention and memory associated to their condition. (2015-03-25)

Multiple sclerosis: Discovery of a mechanism responsible for chronic inflammation
Multiple sclerosis (MS) is an autoimmune disease. The defense system that usually protects patients from external aggression turns on its own cells and attacks them for reasons that are not yet known. Scientists from the Institut Pasteur have shown that ancient viruses are involved in the acute inflammatory defense response that may contribute to the disease. (2019-05-10)

First clues to the causes of multiple sclerosis
There is still no cure for multiple sclerosis, with current treatments largely based on managing symptoms, especially accelerating recovery phases following a relapse and reducing the number and severity of relapses. Researchers at the University of Geneva (UNIGE), Switzerland, and Geneva University Hospitals (HUG) have identified a DNA-binding factor called TOX that might play a role in triggering multiple sclerosis. They found that TOX license immune cells to cause autoimmune tissue destruction in the brain. (2018-05-15)

Low vitamin D levels seen as multiple sclerosis risk for African-Americans, UCSF study finds
In the first major study exploring the connection between vitamin D and multiple sclerosis in African-Americans, a team of scientists at the University of California, San Francisco has discovered that vitamin D levels in the blood are lower in African-Americans who have the disease, compared to African-Americans who do not. (2011-05-27)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to